A citation-based method for searching scientific literature

S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang, R E Fischer, C E Jackson, A Y Lin, C Bäumler, E Siegert, A Marx, A K Vaishnaw, T Grodzicky, T A Fleisher, M J Lenardo. Blood 2001
Times Cited: 307







List of co-cited articles
1109 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
261
42

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
Susan Price, Pamela A Shaw, Amy Seitz, Gyan Joshi, Joie Davis, Julie E Niemela, Katie Perkins, Ronald L Hornung, Les Folio, Philip S Rosenberg,[...]. Blood 2014
128
37

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
34

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
32

How I treat autoimmune lymphoproliferative syndrome.
V Koneti Rao, João Bosco Oliveira. Blood 2011
87
28

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
195
23

A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
Bénédicte Neven, Aude Magerus-Chatinet, Benoit Florkin, Delphine Gobert, Olivier Lambotte, Lien De Somer, Nina Lanzarotti, Marie-Claude Stolzenberg, Brigitte Bader-Meunier, Nathalie Aladjidi,[...]. Blood 2011
89
24

Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Aude Magerus-Chatinet, Bénédicte Neven, Marie-Claude Stolzenberg, Cécile Daussy, Peter D Arkwright, Nina Lanzarotti, Catherine Schaffner, Sophie Cluet-Dennetiere, Filomeen Haerynck, Gérard Michel,[...]. J Clin Invest 2011
78
25

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
472
20

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche,[...]. Blood 2009
96
18

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
232
18

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
Kennichi C Dowdell, Julie E Niemela, Susan Price, Joie Davis, Ronald L Hornung, João Bosco Oliveira, Jennifer M Puck, Elaine S Jaffe, Stefania Pittaluga, Jeffrey I Cohen,[...]. Blood 2010
78
21

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Manuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, Sara Calleja, Jose Gomez-Rial, Ernesto Roldan, Pablo Morales, Antonio Serrano, Alberto Anel, Estela Paz-Artal,[...]. Blood 2006
79
20

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.
Iusta Caminha, Thomas A Fleisher, Ronald L Hornung, Janet K Dale, Julie E Niemela, Susan Price, Joie Davis, Katie Perkins, Kennichi C Dowdell, Margaret R Brown,[...]. J Allergy Clin Immunol 2010
57
28

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.
David T Teachey, Robert Greiner, Alix Seif, Edward Attiyeh, Jack Bleesing, John Choi, Catherine Manno, Eric Rappaport, Dirk Schwabe, Cecilia Sheen,[...]. Br J Haematol 2009
108
14

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
14

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
347
14

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
501
14

Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
Shigui Zhu, Amy P Hsu, Marla M Vacek, Lixin Zheng, Alejandro A Schäffer, Janet K Dale, Joie Davis, Roxanne E Fischer, Stephen E Straus, Donna Boruchov,[...]. Hum Genet 2006
44
29

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
13


Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
R M Siegel, J K Frederiksen, D A Zacharias, F K Chan, M Johnson, D Lynch, R Y Tsien, M J Lenardo. Science 2000
500
13

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
12

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
Lilia L Bi, George Pan, T Prescott Atkinson, Lixin Zheng, Janet K Dale, Christopher Makris, Vishnu Reddy, Jay M McDonald, Richard M Siegel, Jennifer M Puck,[...]. BMC Med Genet 2007
50
24

Pathological findings in human autoimmune lymphoproliferative syndrome.
M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson,[...]. Am J Pathol 1998
146
12


Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
V Koneti Rao, Susan Price, Katie Perkins, Patricia Aldridge, Jean Tretler, Joie Davis, Janet K Dale, Fred Gill, Kip R Hartman, Linda C Stork,[...]. Pediatr Blood Cancer 2009
57
19

Chronic lymphadenopathy simulating malignant lymphoma.
V C Canale, C H Smith. J Pediatr 1967
145
11

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Faith Dugan, Janet K Dale, Joie Davis, Jean Tretler, John K Hurley, Thomas Fleisher, Jennifer Puck, Stephen E Straus. Br J Haematol 2005
77
14

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
149
11

Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
Lorraine A O' Reilly, Lin Tai, Lily Lee, Elizabeth A Kruse, Stephanie Grabow, W Douglas Fairlie, Nicole M Haynes, David M Tarlinton, Jian-Guo Zhang, Gabrielle T Belz,[...]. Nature 2009
270
11

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
Joshua D Milner, Tiphanie P Vogel, Lisa Forbes, Chi A Ma, Asbjørg Stray-Pedersen, Julie E Niemela, Jonathan J Lyons, Karin R Engelhardt, Yu Zhang, Nermina Topcagic,[...]. Blood 2015
313
11

Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.
Christian Klemann, Myrian Esquivel, Aude Magerus-Chatinet, Myriam R Lorenz, Ilka Fuchs, Nathalie Neveux, Martin Castelle, Jan Rohr, Claudia Bettoni da Cunha, Martin Ebinger,[...]. Haematologica 2017
26
42

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.
Julie E Niemela, Lianghao Lu, Thomas A Fleisher, Joie Davis, Iusta Caminha, Marc Natter, Laurel A Beer, Kennichi C Dowdell, Stefania Pittaluga, Mark Raffeld,[...]. Blood 2011
87
11

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
Jana Pachlopnik Schmid, Danielle Canioni, Despina Moshous, Fabien Touzot, Nizar Mahlaoui, Fabian Hauck, Hirokazu Kanegane, Eduardo Lopez-Granados, Ester Mejstrikova, Isabelle Pellier,[...]. Blood 2011
222
10

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
F C Kischkel, S Hellbardt, I Behrmann, M Germer, M Pawlita, P H Krammer, M E Peter. EMBO J 1995
10

Yes and PI3K bind CD95 to signal invasion of glioblastoma.
Susanne Kleber, Ignacio Sancho-Martinez, Benedict Wiestler, Alexandra Beisel, Christian Gieffers, Oliver Hill, Meinolf Thiemann, Wolf Mueller, Jaromir Sykora, Andreas Kuhn,[...]. Cancer Cell 2008
235
10

Autoimmune lymphoproliferative syndrome: an update and review of the literature.
Shaili Shah, Eveline Wu, V Koneti Rao, Teresa K Tarrant. Curr Allergy Asthma Rep 2014
45
22

Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies.
Felipe Suarez, Nizar Mahlaoui, Danielle Canioni, Chantal Andriamanga, Catherine Dubois d'Enghien, Nicole Brousse, Jean-Philippe Jais, Alain Fischer, Olivier Hermine, Dominique Stoppa-Lyonnet. J Clin Oncol 2015
121
10

Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study.
Alix E Seif, Catherine S Manno, Cecilia Sheen, Stephan A Grupp, David T Teachey. Blood 2010
52
17


Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
117
9

IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach.
Polina Stepensky, Michael Weintraub, Asaf Yanir, Shoshana Revel-Vilk, Frank Krux, Kirsten Huck, Rene M Linka, Avraham Shaag, Orly Elpeleg, Arndt Borkhardt,[...]. Haematologica 2011
71
12

X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
Claire Booth, Kimberly C Gilmour, Paul Veys, Andrew R Gennery, Mary A Slatter, Helen Chapel, Paul T Heath, Colin G Steward, Owen Smith, Anna O'Meara,[...]. Blood 2011
175
9

Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Nina Lanzarotti, Bénédicte Neven, Cécile Daussy, Capucine Picard, Nathalie Neveux, Mukesh Desai, Meghana Rao, Kanjaksha Ghosh,[...]. J Allergy Clin Immunol 2013
28
32

Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.
Simon Völkl, Anne Rensing-Ehl, Andrea Allgäuer, Elisabeth Schreiner, Myriam Ricarda Lorenz, Jan Rohr, Christian Klemann, Ilka Fuchs, Volker Schuster, André O von Bueren,[...]. Blood 2016
43
20

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
J J Bleesing, S E Straus, T A Fleisher. Pediatr Clin North Am 2000
61
13

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Alix E Seif, Stephan A Grupp. Br J Haematol 2010
62
12

Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis.
Zhenyue Hao, Gordon S Duncan, Jane Seagal, Yu-Wen Su, Claire Hong, Jillian Haight, Nien-Jung Chen, Andrew Elia, Andrew Wakeham, Wanda Y Li,[...]. Immunity 2008
147
8

Clinical, immunological, and pathological consequences of Fas-deficient conditions.
F Le Deist, J F Emile, F Rieux-Laucat, M Benkerrou, I Roberts, N Brousse, A Fischer. Lancet 1996
152
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.